Ra Capital Management, Llc Buys Orchard Therapeutics PLC, Zogenix Inc, Stoke Therapeutics Inc, Sells InflaRx NV, Biocryst Pharmaceuticals Inc, Sage Therapeutics Inc

• New Purchases: ORTX, STOK, SWAV, ALEC, XFOR, ODT,
• Added Positions: ZGNX, MYOV, GTHX, SCPH,
• Reduced Positions: AXSM, TGTX, ARVN,
• Sold Out: IFRX, BCRX, SAGE, KALV, MNTA, EIGR, MRNA, IOVA,

For the details of RA CAPITAL MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ra+capital+management%2C+llc/current-portfolio/portfolio

1. Ascendis Pharma A/S (ASND) - 4,132,442 shares, 28.07% of the total portfolio.
2. WAVE Life Sciences Ltd (WVE) - 7,775,207 shares, 11.97% of the total portfolio.
3. Zogenix Inc (ZGNX) - 3,722,504 shares, 10.49% of the total portfolio. Shares added by 56.27%
4. Ra Pharmaceuticals Inc (RARX) - 4,858,260 shares, 8.08% of the total portfolio.
5. Eidos Therapeutics Inc (EIDX) - 2,162,671 shares, 6.65% of the total portfolio.

Ra Capital Management, Llc initiated holding in Orchard Therapeutics PLC. The purchase prices were between $13.2 and $20.63, with an estimated average price of $17.58. The stock is now traded at around $14.09. The impact to a portfolio due to this purchase was 4.22%. The holding were 5,108,330 shares as of .

Ra Capital Management, Llc initiated holding in Stoke Therapeutics Inc. The purchase prices were between $25.53 and $29.17, with an estimated average price of $26.85. The stock is now traded at around $32.63. The impact to a portfolio due to this purchase was 1.93%. The holding were 1,119,963 shares as of .

Ra Capital Management, Llc initiated holding in ShockWave Medical Inc. The purchase prices were between $29.73 and $66.02, with an estimated average price of $48.43. The stock is now traded at around $40.70. The impact to a portfolio due to this purchase was 1.67%. The holding were 495,608 shares as of .

Ra Capital Management, Llc initiated holding in Alector Inc. The purchase prices were between $16.26 and $26.42, with an estimated average price of $20.32. The stock is now traded at around $16.00. The impact to a portfolio due to this purchase was 1.12%. The holding were 1,000,000 shares as of .

Ra Capital Management, Llc initiated holding in X4 Pharmaceuticals Inc. The purchase prices were between $12.57 and $21.67, with an estimated average price of $16.91. The stock is now traded at around $12.83. The impact to a portfolio due to this purchase was 0.76%. The holding were 861,393 shares as of .

Ra Capital Management, Llc initiated holding in Odonate Therapeutics Inc. The purchase prices were between $17.27 and $36.69, with an estimated average price of $23.9. The stock is now traded at around $34.52. The impact to a portfolio due to this purchase was 0.43%. The holding were 200,000 shares as of .

Ra Capital Management, Llc added to a holding in Zogenix Inc by 56.27%. The purchase prices were between $36.17 and $54.96, with an estimated average price of $40.18. The stock is now traded at around $50.49. The impact to a portfolio due to this purchase was 3.78%. The holding were 3,722,504 shares as of .

Ra Capital Management, Llc added to a holding in Myovant Sciences Ltd by 84.68%. The purchase prices were between $8.69 and $25, with an estimated average price of $14.93. The stock is now traded at around $7.87. The impact to a portfolio due to this purchase was 1.6%. The holding were 6,545,642 shares as of .

Ra Capital Management, Llc added to a holding in G1 Therapeutics Inc by 33.31%. The purchase prices were between $16.03 and $31.1, with an estimated average price of $21.03. The stock is now traded at around $38.83. The impact to a portfolio due to this purchase was 0.22%. The holding were 483,990 shares as of .

Ra Capital Management, Llc sold out a holding in InflaRx NV. The sale prices were between $3.06 and $51.61, with an estimated average price of $31.98.

Ra Capital Management, Llc sold out a holding in Biocryst Pharmaceuticals Inc. The sale prices were between $2.91 and $9.15, with an estimated average price of $6.01.

Ra Capital Management, Llc sold out a holding in Sage Therapeutics Inc. The sale prices were between $157.85 and $183.09, with an estimated average price of $170.61.

Ra Capital Management, Llc sold out a holding in KalVista Pharmaceuticals Inc. The sale prices were between $18.44 and $30.89, with an estimated average price of $23.49.

Ra Capital Management, Llc sold out a holding in Momenta Pharmaceuticals Inc. The sale prices were between $11.63 and $15, with an estimated average price of $13.27.

Ra Capital Management, Llc sold out a holding in Eiger BioPharmaceuticals Inc. The sale prices were between $9.54 and $14.96, with an estimated average price of $11.53.